<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K/A
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) May 17, 1999
MEDCARE TECHNOLOGIES, INC.
(Exact name of registrant as specified in its charter)
DELAWARE 0-28790 87-0429962B
(State or other (Commission (IRS Employer
jurisdiction of File Number) Identification
incorporation) Number)
1515 West 22nd Street, Oak Brook, Illinois 60523
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code (630) 472-5300
<PAGE>
Item 4 -- Changes in Registrant's Certifying Accountants
- --------------------------------------------------------
On May 10, 1999, Medcare Technologies, Inc., (the "Company") dismissed
Clancy and Co., P.L.L.C., as its independent public accountants.
Clancy and Co., P.L.L.C. were dismissed by the Company after the audit for
the fiscal year ending December 31, 1998. The dismissal was approved by the
Board of Directors. Clancy and Co., P.L.L.C. issued an unqualified audit
opinion on the 1998 year-end financial statements and modified their audit
opinion on the 1997 year-end financial statements to reflect the development
stage status of the Company at that time. During the course of their work, the
Company and Clancy and Co., P.L.L.C. have not had any disagreements on any
matter of accounting principles or practices, financial statement disclosure, or
auditing scope or procedure.
The Company has engaged Arthur Andersen LLP as its new independent public
accountants effective as of the date of the dismissal of its former accountants.
During the Company's two most recent fiscal years prior to the engagement, there
have been no consultations with the newly engaged accountants with regard to
either the application of accounting principle as to any specific transaction,
the type of audit opinion that would be rendered on the Company's financial
statements; or any matter of disagreements with the former accountants.
Item 7 -- Financial Statements and Exhibits
- -------------------------------------------
C. Exhibits:
16 Former Accountants Letter
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Medcare Technologies, Inc.
(Registrant)
By: /s/ Jeffrey S. Aronin
-----------------------
Jeff Aronin
CEO and President
By: /s/ Alan P. Jagiello
---------------------
Alan P. Jagiello
CFO
Date: May 25, 1999
<PAGE>
Exhibit Index
Exhibit Number Description
- -------------- -----------
16 Former Accountants Letter
<PAGE>
EXHIBIT 16
Securities and Exchange Commission
450 Fifth Street N.W.
Washington D.C. 20549
Gentlemen:
We have read Item 4 of the Form 8-K dated May 17, 1999 of Medcare Technologies,
Inc. and are in agreement with the statements contained in the first two
paragraphs therein. We have no basis to agree with other statements of the
registrant contained therein.
Yours very truly,
/s/ Clancy and Co.
---------------------------
Clancy and Co., P.L.L.C.
